Evaluation of outcomes in dogs treated for pyothorax: 46 cases (1983–2001)

Harry W. Boothe Departments of Small Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843

Search for other papers by Harry W. Boothe in
Current site
Google Scholar
PubMed
Close
 DVM, MS, DACVS
,
Lisa M. Howe Departments of Small Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843

Search for other papers by Lisa M. Howe in
Current site
Google Scholar
PubMed
Close
 DVM, PhD, DACVS
,
Dawn M. Boothe Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843

Search for other papers by Dawn M. Boothe in
Current site
Google Scholar
PubMed
Close
 DVM, PhD, DACVIM, DACVCP
,
Loren A. Reynolds Departments of Small Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843

Search for other papers by Loren A. Reynolds in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Mark Carpenter Department of Mathematics and Statistics, College of Sciences and Mathematics, Auburn University, Auburn, AL 36849

Search for other papers by Mark Carpenter in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objective—To determine the effect of treatment approach on outcome and the appropriateness of initial empirical antimicrobial treatment in dogs with pyothorax.

Design—Retrospective case series.

Animals—46 dogs with pyothorax confirmed by either (n = 15) or both (31) of the following: intracellular bacteria in pleural fluid or tissue (41) and bacteria recovered via culture of pleural fluid (36).

Procedures—Medical records of dogs treated for pyothorax from 1983 through 2001 were reviewed. Data on signalment, history, clinical signs, and treatment and results of diagnostic imaging and cytologic and microbiological evaluations were obtained. Follow-up was performed via reexamination (n = 15) and contact with referring veterinarians (26) and owners (24).

Results—46 dogs were treated with at least 1 antimicrobial and thoracocentesis (n = 7; noninvasive group), a thoracostomy tube (26; invasive group) with or without pleural lavage and heparin, or a thoracotomy (13; surgical group) and thoracostomy tube with or without pleural lavage and heparin. Pyothorax recurred in 7 dogs, and 5 of the 7 died or were euthanatized. In the respective groups, the short-term survival rate was 29%, 77%, and 92% and the long-term survival rate was 29%, 71%, and 70%. Pleural lavage and heparin treatment increased the likelihood of short- and long-term survival. Results of antimicrobial susceptibility testing suggested empirical antimicrobial selection was associated with a 35% risk of inefficacy.

Conclusions and Clinical Relevance—In the dogs with pyothorax in this study, favorable treatment effects were achieved with surgery (for short-term survival) and pleural lavage and heparin treatment (for short- and long-term survival). Findings failed to support the hypothesis that invasive (surgical) versus noninvasive treatment of pyothorax in dogs leads to a better long-term outcome.

Abstract

Objective—To determine the effect of treatment approach on outcome and the appropriateness of initial empirical antimicrobial treatment in dogs with pyothorax.

Design—Retrospective case series.

Animals—46 dogs with pyothorax confirmed by either (n = 15) or both (31) of the following: intracellular bacteria in pleural fluid or tissue (41) and bacteria recovered via culture of pleural fluid (36).

Procedures—Medical records of dogs treated for pyothorax from 1983 through 2001 were reviewed. Data on signalment, history, clinical signs, and treatment and results of diagnostic imaging and cytologic and microbiological evaluations were obtained. Follow-up was performed via reexamination (n = 15) and contact with referring veterinarians (26) and owners (24).

Results—46 dogs were treated with at least 1 antimicrobial and thoracocentesis (n = 7; noninvasive group), a thoracostomy tube (26; invasive group) with or without pleural lavage and heparin, or a thoracotomy (13; surgical group) and thoracostomy tube with or without pleural lavage and heparin. Pyothorax recurred in 7 dogs, and 5 of the 7 died or were euthanatized. In the respective groups, the short-term survival rate was 29%, 77%, and 92% and the long-term survival rate was 29%, 71%, and 70%. Pleural lavage and heparin treatment increased the likelihood of short- and long-term survival. Results of antimicrobial susceptibility testing suggested empirical antimicrobial selection was associated with a 35% risk of inefficacy.

Conclusions and Clinical Relevance—In the dogs with pyothorax in this study, favorable treatment effects were achieved with surgery (for short-term survival) and pleural lavage and heparin treatment (for short- and long-term survival). Findings failed to support the hypothesis that invasive (surgical) versus noninvasive treatment of pyothorax in dogs leads to a better long-term outcome.

Contributor Notes

Dr. Harry Boothe's present address is the Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Dr. Dawn Boothe's present address is the Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.

Dr. Reynolds' present address is Los Gatos Dog and Cat Hospital, 17480 Shelburne Ave, Los Gatos, CA 95030.

Presented as a poster at the American College of Veterinary Surgeons Veterinary Symposium, Orlando, Fla, October 1997.

Address correspondence to Dr. Harry Boothe (boothhw@auburn.edu).
  • 1.

    Marino DJ, Jaggy A. Nocardiosis. A literature review with selected case reports in two dogs. J Vet Intern Med 1993;7:411.

  • 2.

    Steyn PF, Wittum TE. Radiographic, epidemiologic, and clinical aspects of simultaneous pleural and peritoneal effusions in dogs and cats: 48 cases (1982–1991). J Am Vet Med Assoc 1993;202:307312.

    • Search Google Scholar
    • Export Citation
  • 3.

    Demetriou JL, Foale RD, Ladlow J, et al. Canine and feline pyothorax: a retrospective study of 50 cases in the UK and Ireland. J Small Anim Pract 2002;43:388394.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Bauer T. Pyothorax. In: Kirk RW, ed. Current veterinary therapy IX. Philadelphia: WB Saunders Co, 1986;292295.

  • 5.

    Johnson MS, Martin MWS. Successful medical treatment of 15 dogs with pyothorax. J Small Anim Pract 2007;48:1216.

  • 6.

    Frendin J. Pyogranulomatous pleuritis with empyema in hunting dogs. Zentralbl Veterinarmed A 1997;44:167178.

  • 7.

    Robertson SA, Stoddart ME, Evans RJ, et al. Thoracic empyema in the dog; a report of twenty-two cases. J Small Anim Pract 1983;24:103119.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Turner WD, Breznock EM. Continuous suction drainage for management of canine pyothorax—a retrospective study. J Am Anim Hosp Assoc 1988;24:485494.

    • Search Google Scholar
    • Export Citation
  • 9.

    Rooney MB, Monnet E. Medical and surgical treatment of pyothorax in dogs: 26 cases (1991–2001). J Am Vet Med Assoc 2002;221:8692.

  • 10.

    National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. NCCLS M31–A2. 2nd ed. Wayne, Pa: National Committee for Clinical Laboratory Standards, 2003.

    • Search Google Scholar
    • Export Citation
  • 11.

    Walker AL, Jang SS, Hirsh DC. Bacteria associated with pyothorax of dogs and cats: 98 cases (1989–1998). J Am Vet Med Assoc 2000;216:359363.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Jang SS, Breher JE, Dabaco LA, et al. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents. J Am Vet Med Assoc 1997;210:16101614.

    • Search Google Scholar
    • Export Citation
  • 13.

    Hirsh DC, Jang SS. Antimicrobial susceptibility of selected infectious bacterial agents obtained from dogs. J Am Anim Hosp Assoc 1994;30:487494.

    • Search Google Scholar
    • Export Citation
  • 14.

    Holmberg DL. Management of pyothorax. Vet Clin North Am Small Anim Pract 1979;9:357362.

  • 15.

    Tomlinson J. Review of pyothorax in the feline. Feline Pract 1980;10 (6):2632.

  • 16.

    Strange C, Baumann MH, Sahn SA, et al. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med 1995;151:508515.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Sherding RG. Pyothorax in the cat. Compend Contin Educ Pract Vet 1979;1:247252.

  • 18.

    Crane SW. Surgical management of feline pyothorax. Feline Pract 1976;6 (2):1319.

  • 19.

    Forrester SD. Pleural effusion in the dog and cat. Vet Annu 1980;30:283297.

  • 20.

    Hau T, Simmons RL. Heparin in the treatment of experimental peritonitis. Ann Surg 1978;187:294298.

  • 21.

    Stovroff M, Teague G, Heiss KF, et al. Thoracoscopy in the management of pediatric empyema. J Pediatr Surg 1995;30:12111215.

  • 22.

    Stowater JL, Lamb CR. Ultrasonography of noncardiac thoracic diseases in small animals. J Am Vet Med Assoc 1989;195:514520.

  • 23.

    Dechman G, Mishima M, Bates JHT. Assessment of acute pleural effusion in dogs by computed tomography. J Appl Physiol 1994;76:19931998.

  • 24.

    Campbell PW III. New developments in pediatric pneumonia and empyema. Curr Opin Pediatr 1995;7:278282.

  • 25.

    Poe RH, Marin MG, Israel RH, et al. Utility of pleural fluid analysis in predicting tube thoracostomy/decortication in parapneumonic effusions. Chest 1991;100:963967.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Kovak JR, Ludwig LL, Bergman PJ, et al. Use of thoracoscopy to determine the etiology of pleural effusion in dogs and cats: 18 cases (1998–2001). J Am Vet Med Assoc 2002;221:990994.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement